Status:
TERMINATED
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
Lead Sponsor:
Vanderbilt University
Collaborating Sponsors:
Procter and Gamble
Conditions:
Crohn's Disease
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Brief Summary
The primary purpose of this study is to pilot test an instrument that the investigators will develop to assess decision influences on inflammatory bowel disease patients' medication adherence decision...
Detailed Description
Clinical research has produced significant advances in the pharmacologic management of inflammatory bowel disease (IBD). Preliminary research, however, suggest that patient non-adherence may be blunti...
Eligibility Criteria
Inclusion
- All Vanderbilt University Medical Center IBD patients that are 18 years or older
- Those who volunteered to participate in this online web-based survey study.
Exclusion
- Vanderbilt University Medical Center patients unable to take the survey because they do not have an e-mail address or access to one.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00968721
Start Date
June 1 2010
End Date
December 1 2011
Last Update
May 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University
Nashville, Tennessee, United States, 37232